Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Kaddurah-Daouk, Rima
Soares, Jair C.
and
Quinones, Marlon P.
2008.
Biomarkers for Psychiatric Disorders.
p.
129.
Sicras-Mainar, Antoni
Blanca-Tamayo, Milagrosa
Rejas-Gutiérrez, Javier
and
Navarro-Artieda, Ruth
2008.
Síndrome metabólico en pacientes ambulatorios con tratamiento antipsicótico en la práctica clínica habitual: evaluación transversal de una base de datos de atención primaria.
European psychiatry (Ed. Española),
Vol. 15,
Issue. 5,
p.
219.
De Hert, Marc
Schreurs, Vincent
Sweers, Kim
Van Eyck, Dominique
Hanssens, Linda
Šinko, Sebastjan
Wampers, Martien
Scheen, Andre
Peuskens, Joseph
and
van Winkel, Ruud
2008.
Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: A retrospective chart review.
Schizophrenia Research,
Vol. 101,
Issue. 1-3,
p.
295.
DE HERT, MARC
SCHREURS, VINCENT
VANCAMPFORT, DAVY
and
VAN WINKEL, RUUD
2009.
Metabolic syndrome in people with schizophrenia: a review.
World Psychiatry,
Vol. 8,
Issue. 1,
p.
15.
Gentile, S.
2009.
Contributing factors to weight gain during long‐term treatment with second‐generation antipsychotics. A systematic appraisal and clinical implications.
Obesity Reviews,
Vol. 10,
Issue. 5,
p.
527.
Sicras-Mainar, Antoni
Navarro-Artieda, Ruth
Blanca-Tamayo, Milagrosa
Velasco-Velasco, Soledad
Escribano-Herranz, Esperanza
Llopart-López, Josep Ramon
Violan-Fors, Concepción
Vilaseca-Llobet, Josep Maria
Sánchez-Fontcuberta, Encarna
Benavent-Areu, Jaume
Flor-Serra, Ferran
Aguado-Jodar, Alba
Rodríguez-López, Daniel
Prados-Torres, Alejandra
and
Estelrich-Bennasar, Jose
2009.
The relationship between effectiveness and costs measured by a risk-adjusted case-mix system: multicentre study of Catalonian population data bases.
BMC Public Health,
Vol. 9,
Issue. 1,
Panagiotopoulos, Constadina
Ronsley, Rebecca
and
Davidson, Jana
2009.
Increased Prevalence of Obesity and Glucose Intolerance in Youth Treated with Second—Generation Antipsychotic Medications.
The Canadian Journal of Psychiatry,
Vol. 54,
Issue. 11,
p.
743.
Yatham, Lakshmi N
Kennedy, Sidney H
Schaffer, Ayal
Parikh, Sagar V
Beaulieu, Serge
O'Donovan, Claire
MacQueen, Glenda
McIntyre, Roger S
Sharma, Verinder
Ravindran, Arun
Young, L Trevor
Young, Allan H
Alda, Martin
Milev, Roumen
Vieta, Eduard
Calabrese, Joseph R
Berk, Michael
Ha, Kyooseob
and
Kapczinski, Flávio
2009.
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.
Bipolar Disorders,
Vol. 11,
Issue. 3,
p.
225.
2009.
Current World Literature.
Current Opinion in Lipidology,
Vol. 20,
Issue. 2,
p.
135.
Rice, Michael J.
2010.
Evidence-Based Practice Problems: Form and Focus.
Journal of the American Psychiatric Nurses Association,
Vol. 16,
Issue. 5,
p.
307.
McIntyre, Roger S.
Danilewitz, Marlon
Liauw, Samantha S.
Kemp, David E.
Nguyen, Ha T.T.
Kahn, Linda S.
Kucyi, Aaron
Soczynska, Joanna K.
Woldeyohannes, Hanna O.
Lachowski, Angela
Kim, Byungsu
Nathanson, Jay
Alsuwaidan, Mohammad
and
Taylor, Valerie H.
2010.
Bipolar disorder and metabolic syndrome: An international perspective.
Journal of Affective Disorders,
Vol. 126,
Issue. 3,
p.
366.
Lee, Nam Young
Kim, Se Hyun
Cho, Belong
Lee, Yeon Ji
Chang, Jae Seung
Kang, Ung Gu
Kim, Yong Sik
and
Ahn, Yong Min
2010.
Patients taking medications for bipolar disorder are more prone to metabolic syndrome than Korea's general population.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 34,
Issue. 7,
p.
1243.
Sugawara, Norio
Yasui-Furukori, Norio
Sato, Yasushi
Umeda, Takashi
Kishida, Ikuko
Yamashita, Hakuei
Saito, Manabu
Furukori, Hanako
Nakagami, Taku
Hatakeyama, Mitsunori
Nakaji, Shigeyuki
and
Kaneko, Sunao
2010.
Prevalence of metabolic syndrome among patients with schizophrenia in Japan.
Schizophrenia Research,
Vol. 123,
Issue. 2-3,
p.
244.
Vemuri, Mytilee
Kenna, Heather A.
Wang, Po W.
Ketter, Terence A.
and
Rasgon, Natalie L.
2011.
Gender-specific lipid profiles in patients with bipolar disorder.
Journal of Psychiatric Research,
Vol. 45,
Issue. 8,
p.
1036.
Marcus, Ronald
Khan, Arif
Rollin, Linda
Morris, Beth
Timko, Karen
Carson, William
and
Sanchez, Raymond
2011.
Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study.
Bipolar Disorders,
Vol. 13,
Issue. 2,
p.
133.
Panagiotopoulos, Constadina
Ronsley, Rebecca
Kuzeljevic, Boris
and
Davidson, Jana
2012.
Waist Circumference is a Sensitive Screening Tool for Assessment of Metabolic Syndrome Risk in Children Treated with Second-Generation Antipsychotics.
The Canadian Journal of Psychiatry,
Vol. 57,
Issue. 1,
p.
34.
Carlson, Berit X
Ketter, Terence A
Sun, Wei
Timko, Karen
McQuade, Robert D
Sanchez, Raymond
Vester‐Blokland, Estelle
and
Marcus, Ronald
2012.
Aripiprazole in combination with lamotrigine for the long‐term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double‐blind study (CN138‐392).
Bipolar Disorders,
Vol. 14,
Issue. 1,
p.
41.
Erickson, Sara C.
Le, Lisa
Zakharyan, Armen
Stockl, Karen M.
Harada, Ann S. M.
Borson, Soo
Ramsey, Scott D.
and
Curtis, Bradford
2012.
New‐Onset Treatment‐Dependent Diabetes Mellitus and Hyperlipidemia Associated with Atypical Antipsychotic Use in Older Adults without Schizophrenia or Bipolar Disorder.
Journal of the American Geriatrics Society,
Vol. 60,
Issue. 3,
p.
474.
Czepielewski, Letícia
Filho, Ledo Daruy
Brietzke, Elisa
and
Grassi-Oliveira, Rodrigo
2013.
Bipolar Disorder and Metabolic Syndrome: A Systematic Review.
Revista Brasileira de Psiquiatria,
Vol. 35,
Issue. 1,
p.
88.
Foguet Boreu, Quintí
Roura Poch, Pere
Bullón Chia, Anna
Mauri Martin, Cristina
Gordo Serra, Núria
and
Cecília Costa, Raquel
2013.
Factores de riesgo cardiovascular, riesgo cardiovascular y calidad de vida en pacientes con trastorno mental severo.
Atención Primaria,
Vol. 45,
Issue. 3,
p.
141.
Comments
No Comments have been published for this article.